Labiana Health (XMAD:LAB) Debt-to-Equity : 5.43 (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Debt-to-Equity?

Labiana Health's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €20.01 Mil. Labiana Health's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2022 was €18.19 Mil. Labiana Health's Total Stockholders Equity for the quarter that ended in Dec. 2022 was €7.04 Mil. Labiana Health's debt to equity for the quarter that ended in Dec. 2022 was 5.43.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Labiana Health's Debt-to-Equity or its related term are showing as below:

XMAD:LAB's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

Labiana Health Debt-to-Equity Historical Data

The historical data trend for Labiana Health's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Debt-to-Equity Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Debt-to-Equity

2.71

3.86

5.43

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Debt-to-Equity	2.71	3.86	2.89	5.43

Competitive Comparison of Labiana Health's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Labiana Health's Debt-to-Equity falls into.

Labiana Health Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Labiana Health's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(20.008	+	18.189)	/	7.035
	=	5.43

Labiana Health's Debt to Equity Ratio for the quarter that ended in Dec. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(20.008	+	18.189)	/	7.035
	=	5.43

Labiana Health (XMAD:LAB) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Labiana Health Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Labiana Health's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.